Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency

Coenzyme Q10 (CoQ10) is essential for electron transport in the mitochondrial respiratory chain and antioxidant defense. Last year, we re ported the first mutations in CoQ10 biosynthetic genes, COQ2, which encodes 4‐parahydroxybenzoate: polyprenyl transferase;and PDSS2, which encodes subunit 2 of decaprenyl diphosphate synthase. How ever, the pathogenic mechanisms of primary CoQ10deficiency have not been well characterized. In this study, we investigated the consequence of severe CoQ10 deficiency on bioenergetics, oxidative stress, and antioxidant defenses in cultured skin fibroblasts harboring COQ2 and PDSS2 mutations. Defects in the first two committed steps of the CoQ10 biosynthetic pathway produce different biochemical alterations. PDSS2 mutant fibroblasts have 12% CoQ10 relative to control cells and markedly reduced ATP synthesis, but do not show increased reactive oxygen species (ROS) production, signs of oxidative stress, or in creased antioxidant defense markers. In contrast, COQ2 mutant fibroblasts have 30% CoQ10 with par tial defect in ATP synthesis, as well as significantly increased ROS production and oxidation of lipids and proteins. On the basis of a small number of cell lines, our results suggest that primary CoQ10 defi ciencies cause variable defects of ATP synthesis and oxidative stress, which may explain the different clinical features and may lead to more rational therapeutic strategies.— Quinzii, C. M., López, L. C., Von‐Moltke, J., Naini, A., Krishna, S., Schuelke, M., Salviati, L., Navas, P., DiMauro, S., Hirano, M. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J. 22, 1874–1885 (2008)

[1]  E. Bertini,et al.  COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. , 2007, Journal of the American Society of Nephrology : JASN.

[2]  E. Pagnotta,et al.  Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. , 2007, Biochimica et biophysica acta.

[3]  K. Brismar,et al.  The antioxidant role of coenzyme Q. , 2007, Mitochondrion.

[4]  M. L. Genova,et al.  The role of Coenzyme Q in mitochondrial electron transport. , 2007, Mitochondrion.

[5]  S. Dimauro,et al.  Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis. , 2007, Human molecular genetics.

[6]  R. de Cabo,et al.  The importance of plasma membrane coenzyme Q in aging and stress responses. , 2007, Mitochondrion.

[7]  A. Munnich,et al.  Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. , 2007, The Journal of clinical investigation.

[8]  S. Dimauro,et al.  Mutations in coenzyme Q10 biosynthetic genes. , 2007, The Journal of clinical investigation.

[9]  A. Durr,et al.  Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1 , 2007, Neurology.

[10]  P. Bernardi,et al.  Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphate , 2006, Proceedings of the National Academy of Sciences.

[11]  S. Dimauro,et al.  Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. , 2006, American journal of human genetics.

[12]  A. Barrientos,et al.  Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. , 2006, Human molecular genetics.

[13]  V. Volpini,et al.  Cerebellar ataxia with coenzyme Q10 deficiency: Diagnosis and follow-up after coenzyme Q10 supplementation , 2006, Journal of the Neurological Sciences.

[14]  P. Kaufmann,et al.  Mitochondrial neurology I: encephalopathies , 2006 .

[15]  V. Petruzzella,et al.  Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I* , 2006, Journal of Biological Chemistry.

[16]  S. Dimauro,et al.  A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. , 2006, American journal of human genetics.

[17]  S. Dimauro,et al.  Coenzyme Q10 deficiency and isolated myopathy , 2006, Neurology.

[18]  S. Dimauro,et al.  Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition , 2005, Neurology.

[19]  L. Gille,et al.  Lysosomal ROS formation , 2005, Redox report : communications in free radical research.

[20]  Elena Bisetto,et al.  Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy , 2005, The FEBS journal.

[21]  V. Mootha,et al.  Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation , 2005, Neurology.

[22]  S. Lalani,et al.  Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. , 2005, Archives of neurology.

[23]  S. Dimauro,et al.  Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. , 2004, The Biochemical journal.

[24]  A. J. Lambert,et al.  Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. , 2004, Free radical biology & medicine.

[25]  N. Romero,et al.  Progression despite replacement of a myopathic form of coenzyme Q10 defect , 2004, Neurology.

[26]  M. Wiedmann,et al.  The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. , 2004, Human molecular genetics.

[27]  N. Bresolin,et al.  Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency , 2004, Neurology.

[28]  G. Dallner,et al.  Metabolism and function of coenzyme Q. , 2004, Biochimica et biophysica acta.

[29]  L. Partridge,et al.  Superoxide and hydrogen peroxide production by Drosophila mitochondria. , 2003, Free radical biology & medicine.

[30]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[31]  D. Lynch,et al.  Cerebellar ataxia and coenzyme Q10 deficiency , 2003, Neurology.

[32]  M. Brand,et al.  Topology of Superoxide Production from Different Sites in the Mitochondrial Electron Transport Chain* , 2002, The Journal of Biological Chemistry.

[33]  Lichuan Yang,et al.  Measurements of ATP in mammalian cells. , 2002, Methods.

[34]  P. Clayton,et al.  Neonatal presentation of coenzyme Q10 deficiency. , 2001, The Journal of pediatrics.

[35]  S. Di Giovanni,et al.  Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency , 2001, Neurology.

[36]  S. Dimauro,et al.  Familial cerebellar ataxia with muscle coenzyme Q10 deficiency , 2001, Neurology.

[37]  A. Munnich,et al.  Human cultured skin fibroblasts survive profound inherited ubiquinone depletion , 2001, Free radical research.

[38]  M. Kawamukai,et al.  Phenotypes of Fission Yeast Defective in Ubiquinone Production Due to Disruption of the Gene for p-Hydroxybenzoate Polyprenyl Diphosphate Transferase , 2000, Journal of bacteriology.

[39]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[40]  A. Munnich,et al.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.

[41]  Douglas C. Wallace,et al.  Coordinate Induction of Energy Gene Expression in Tissues of Mitochondrial Disease Patients* , 1999, The Journal of Biological Chemistry.

[42]  P. Rustin,et al.  A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency , 1998, Journal of the Neurological Sciences.

[43]  S. Dimauro,et al.  Mitochondrial encephalomyopathy with coenzyme Q10 deficiency , 1997, Neurology.

[44]  Dean P. Jones,et al.  Compartmentation of glutathione: implications for the study of toxicity and disease. , 1996, Toxicology and applied pharmacology.

[45]  D. Wallace,et al.  Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. , 1992, Biochemical medicine and metabolic biology.

[46]  D. Frens,et al.  Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Landi,et al.  Effect of ubiquinone extraction on ubiquinol-1 oxidase activity in beef heart mitochondria , 1981, Journal of bioenergetics and biomembranes.

[48]  E. Nissinen,et al.  The energy charge in wild‐type and respiration‐deficient chinese hamster cell mutants , 1980, Journal of cellular physiology.

[49]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[50]  G. López-Lluch,et al.  Coenzyme Q and the regulation of intracellular steady‐state levels of superoxide in HL‐60 cells , 2005, BioFactors.

[51]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.